Diversified Supply Chains And PetRx Integration Will Secure Future Success

AN
AnalystConsensusTarget
Consensus Narrative from 27 Analysts
Published
08 Aug 24
Updated
31 Jul 25
AnalystConsensusTarget's Fair Value
US$62.04
7.1% undervalued intrinsic discount
31 Jul
US$57.63
Loading
1Y
12.5%
7D
-0.8%

Author's Valuation

US$62.0

7.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Increased 13%

Shared on30 Apr 25
Fair value Decreased 6.12%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 0.10%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 0.31%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 0.74%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 0.069%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Increased 5.95%

AnalystConsensusTarget has increased discount rate from 7.1% to 7.9%.